SNYR
Synergy CHC·NASDAQ
--
--(--)
--
--(--)
SNYR fundamentals
Synergy CHC (SNYR) Revenue Breakdown: Q3 2025 Business & Regional Performance
Synergy CHC (SNYR) reported total revenue of 8.01M USD in Q3 2025, with its core business segment Nutraceuticals contributing 100.00%. Regionally, United States remained the largest market, accounting for 88.36% of total revenue. Explore Synergy CHC's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Synergy CHC (SNYR) reported total revenue of 8.01M USD in Q3 2025, with its core business segment Nutraceuticals contributing 100.00%. Regionally, United States remained the largest market, accounting for 88.36% of total revenue. Explore Synergy CHC's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Synergy CHC’s earnings call?What is Synergy CHC's gross profit margin?What is the market's earnings forecast for Synergy CHC next quarter?Did Synergy CHC beat or miss consensus estimates last quarter?What were the key takeaways from Synergy CHC's earnings call?What factors drove the changes in Synergy CHC's revenue and profit?What is the revenue and EPS growth rate for Synergy CHC year over year?What is Synergy CHC's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
